Tr
Treeline
Boston MAFounded 202140 employees
Private CapbiotechPrivateOncology
Platform: Chromatin
Market Cap
N/A
All Drugs
4
Clinical Trials
5
Failed / Terminated
1
FDA Approved
0
Drug Pipeline (4 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| TRE-8359 | TRE-8359 | Preclinical | 1 | SMN2 | PAHMS | ||
| TRE-5650 | TRE-5650 | Phase 1/2 | 1 | AHR | Urothelial CaCKD | ||
| Doxarelsin | TRE-4639 | Phase 1/2 | 1 | PD-1 | ACCGBM | ||
| TRE-2745 | TRE-2745 | Phase 2/3 | 2 | EGFR | PAH |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (7)